Annual Cash & Cash Equivalents
$142.13 M
-$109.05 M-43.41%
December 31, 2024
Summary
- As of March 13, 2025, ITOS annual cash & cash equivalents is $142.13 million, with the most recent change of -$109.05 million (-43.41%) on December 31, 2024.
- During the last 3 years, ITOS annual cash & cash equivalents has fallen by -$706.41 million (-83.25%).
- ITOS annual cash & cash equivalents is now -83.25% below its all-time high of $848.54 million, reached on December 31, 2021.
Performance
ITOS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$142.13 M
+$18.39 M+14.86%
December 31, 2024
Summary
- As of March 13, 2025, ITOS quarterly cash and cash equivalents is $142.13 million, with the most recent change of +$18.39 million (+14.86%) on December 31, 2024.
- Over the past year, ITOS quarterly cash and cash equivalents has increased by +$18.39 million (+14.86%).
- ITOS quarterly cash and cash equivalents is now -84.20% below its all-time high of $899.77 million, reached on September 30, 2021.
Performance
ITOS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ITOS Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -43.4% | +14.9% |
| 3 y3 years | -83.3% | -83.3% |
| 5 y5 years | +615.4% | +615.4% |
ITOS Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -83.3% | at low | -83.3% | +14.9% |
| 5 y | 5-year | -83.3% | +615.4% | -84.2% | +615.4% |
| alltime | all time | -83.3% | +615.4% | -84.2% | +615.4% |
ITeos Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $142.13 M(-43.4%) | $142.13 M(+14.9%) |
| Sep 2024 | - | $123.74 M(-50.7%) |
| Jun 2024 | - | $251.10 M(+71.2%) |
| Mar 2024 | - | $146.65 M(-41.6%) |
| Dec 2023 | $251.18 M(-11.8%) | $251.18 M(+23.0%) |
| Sep 2023 | - | $204.13 M(-5.6%) |
| Jun 2023 | - | $216.21 M(-4.1%) |
| Mar 2023 | - | $225.36 M(-20.9%) |
| Dec 2022 | $284.80 M | $284.80 M(-62.1%) |
| Sep 2022 | - | $752.24 M(-5.0%) |
| Jun 2022 | - | $791.86 M(-3.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $823.98 M(-2.9%) |
| Dec 2021 | $848.54 M(+152.3%) | $848.54 M(-5.7%) |
| Sep 2021 | - | $899.77 M(+197.0%) |
| Jun 2021 | - | $302.93 M(-5.7%) |
| Mar 2021 | - | $321.38 M(-4.4%) |
| Dec 2020 | $336.33 M(+1592.8%) | $336.33 M(-1.1%) |
| Sep 2020 | - | $339.98 M(+148.4%) |
| Jun 2020 | - | $136.87 M(-7.4%) |
| Mar 2020 | - | $147.73 M(+643.6%) |
| Dec 2019 | $19.87 M(-9.6%) | $19.87 M |
| Dec 2018 | $21.99 M | - |
FAQ
- What is iTeos Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for iTeos Therapeutics?
- What is iTeos Therapeutics annual cash & cash equivalents year-on-year change?
- What is iTeos Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for iTeos Therapeutics?
- What is iTeos Therapeutics quarterly cash and cash equivalents year-on-year change?
What is iTeos Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of ITOS is $142.13 M
What is the all time high annual cash & cash equivalents for iTeos Therapeutics?
iTeos Therapeutics all-time high annual cash & cash equivalents is $848.54 M
What is iTeos Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, ITOS annual cash & cash equivalents has changed by -$109.05 M (-43.41%)
What is iTeos Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ITOS is $142.13 M
What is the all time high quarterly cash and cash equivalents for iTeos Therapeutics?
iTeos Therapeutics all-time high quarterly cash and cash equivalents is $899.77 M
What is iTeos Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, ITOS quarterly cash and cash equivalents has changed by +$18.39 M (+14.86%)